2023 Agenda

Time

Event

7:00 am –  Villard Foyer

Registration & Morning Coffee

8:25 am –  Villard Ballroom

Welcome Back
Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am – Villard Ballroom

Opening “Big Think” Plenary Session
Supercharging Therapeutic Development:
Next-Gen Technology & Therapeutic Innovation that You’ve Never Heard Of

Moderator:
Querida Anderson, Editorial Director & Biopharma Expert

Panelists:
Vincent Beltrani, PhD, Enterprise Customer Engineer: Healthcare, Life Sciences and Quantum AI, Google
Eric Elenko, PhD, Chief Innovation & Strategy Officer, PureTech
Walter Greenleaf, PhD, Distinguished Visiting Scholar, MediaX, Stanford University
Susan Lenderts, General Manager, US Life Sciences, SAS

9:30 am – Holmes I

Dialogue 1A
Molding the Mind:
Pushing the Boundaries of Neuroscience with Brain Plasticity

Moderator:
Caroline Montojo, PhD, President & CEO, Dana Foundation

Panelists:
Ryan Field, CEO, Kernel
Kurt Haggstrom, Chief Commercial Officer, Synchron
Beth Rogozinski, CEO, Oncoustics
Brent Vaughan, CEO, Cognito Therapeutics

9:30 am – Holmes II

Dialogue 1B
Alternative Financing:
Options for Life Science Companies During a Market Downturn

Moderator:
Kate Walsh, Managing Director, HSBC Innovation Banking

Panelists:
Shaun Bagai, CEO, RenovoRx
Daniella Kranjac, Founding General Partner, Dynamk Capital
Art Pappas, CEO & Managing General Partner, Pappas Capital
Brad Sitko, Chief Investment Officer, XOMA

9:30 am – 12:30 pm
Louis/Stanford/Rutherford

One-To-Ones

10:15 am
Adams/Kennedy I/Kennedy II

Presenting Companies

11:45 am – Holmes I

Dialogue 2A
Longevity:
Stopping Age-Related Disease at the Cellular Level

Moderator:
Hilary Brueck, Correspondent, Insider

Panelists:
Jenna Brager, PhD, Executive VP, Drug Development, MyMD Pharmaceuticals
Daniel Oliver, Rejuvenate Bio
Thomas Seoh, Executive Vice President, Kitalys Institute
Ali Siam, CBO, Rubedo Life Sciences
Sourav Sinha, General Partner & Head of Strategy, Longevity Vision Fund

11:45 am – Holmes II

Dialogue 2B
New Diagnostics:
AI-Enabled to Reveal Disease Trajectory & Suggest Optimal Treatment

Moderator:
Zegbeh Jallah, PhD, Managing Director, Head of Biotech Equity Research, Capital One

Panelists:
Dusty Majumdar, PhD, CEO, PredxBio
Beth Rogozinski, CEO, Oncoustics
Ajit Singh, PhD, Partner, Artiman Ventures

11:45 am – Kennedy I 

Dialogue 2C
Clinical Trials:
Unleashing AI to Streamline the Process, Saving Time & Money

Moderator:
Susan Rosenthal, Senior Vice President, Life Sciences and Healthcare, New York City Economic Development Corporation

Panelists:
Seth Flaum, Partner, Wilson Sonsini
Kwame Okrah, PhD, Director, Artificial Intelligence & Machine Learning, Sanavia Oncology
Angela Radcliffe, Founder, How Mighty We Ventures
John Wagner, MD, PhD, Chief Medical Officer, Koneksa

12:30 pm – Villard Ballroom

“Big Think" Lunch Plenary
The Shifting Regulatory Landscape:
What Does It All Mean?
The IRA, FTC, Scott-Hart-Rodino, and the TRIPS Waiver are all challenges for industry. What solutions are attainable?

Moderator:
David Ewing Duncan, Journalist, Author, Researcher

Panelists:
Jennifer Hawks Bland, CEO, NewYorkBio
Nouhad Husseini, SVP, Business Development & Corporate Strategy, Regeneron Pharmaceuticals
Dennis Purcell, Founder, Aisling Capital
Nick Shipley, Executive Vice President, BIO

2:00 pm
Adams/Kennedy I/Kennedy II

Presenting Companies

2:00 pm – 4:45 pm
Louis/Stanford/Rutherford

One-To-Ones

3:00 pm – Holmes I

Dialogue 3A
Rewriting the Code:
Navigating the Frontier of Gene & Cell Therapy 

Moderator:
Lei Lei Wu, Reporter, Endpoints News

Panelists:
Sean Ainsworth, CEO, Immusoft
Greg Kunst, CEO, Aurion Biotech
Christine Silverstein, CFO, Excision BioTheraputics
Elizabeth Wood, PhD, Founder & CEO, JURA Bio

3:00 pm – Holmes II

Dialogue 3B
Venturing into the Future:
Exploring Novel Investment Frontiers 

Moderator:
Derek Brand, Executive Director, Strategic Partnerships, Columbia University

Panelists:
Anna Barry, PhD, Venture Partner, Deerfield
Nessan Bermingham, PhD, Operating Partner, Khosla Ventures
Nate Chang, Operating Partner, Playground Global
Jakob Dupont, MD, Executive Partner, Private Equity, Sofinnova Investments

3:00 pm – Kennedy I

Dialogue 3C
Clinical Virtual Reality:
Revolutionizing Next Generation Assessments & Care

Moderator:
Walter Greenleaf, PhD, Distinguished Visiting Scholar, mediaX – Stanford University

Panelists:
JoAnn Difede, PhD, Professor of Psychology, Weill Cornell Medicine
Mark Edwards, CEO & Co-Founder, ViewMind
Georgia Mitsi, PhD, Entrepreneur in Residence, Emerald BioVentures

3:45 pm

Presenting Companies

4:45 pm – Villard Ballroom

End of Day “Big Think" Plenary Session
The Lake Nona Project:
Learnings From a Purpose-Built Experimental Community for Health and Wellness
What started as a 17 square mile cow pasture in Orlando has grown into the world’s first purpose-built community centered around health, wellness, and innovation. This session will explore learnings from the development of Lake Nona, and how resetting the thinking around healthcare through intentional community design can drive better mental and physical health outcomes for residents.

Moderator:
Jeremy Abbate, VP & Publisher, Scientific American

Panelists:
Gloria Caulfield, Vice President, Strategic Alliances, Tavistock Development Company
Timothy Cooke, Medical Center Director/CEO, Orlando VA Healthcare System (VAHCS)

6:30 pm – 345 Park Avenue South

Reception @ Cure

Time

Event

7:00 am – Villard Foyer

Registration & Morning Coffee

8:20 am – Villard Ballroom

Welcome Back
Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am – Villard Ballroom

Opening “Big Think” Plenary Session
A Fireside Chat with Andy Plump:
What Will It Take to Deliver Cures to Society
Our unprecedented knowledge of human biology and disease is unlocking the potential to treat—and even cure—devastating diseases like never before. Simultaneously, innovations in data, digital and technology are revolutionizing our ability to discover, develop and deliver transformational medicines to patients. Explore what it will take to leverage the powerful technical tools at our disposal to bring the next generation of transformational medicines to patients.

Interviewer:
Seema Kumar, CEO, Cure

Interviewee:
Andy Plump, MD, PhD, President of R&D, Takeda

9:30 am
Adams/Kennedy I/Kennedy II

Presenting Companies

9:30 am – 12:30 pm
Louis/Stanford/Rutherford

One-To-Ones

10:30 am – Holmes I

Dialogue 4A
Oncology:
New Tactics to Turn Off Cancer

Moderator:
Jay Campbell, Managing Director, Clinical Accelerator & Venture Fund, Cancer Research Institute (CRI)

Panelists:
Roy de Souza, CEO, BreakBio
Michael Goldberg, PhD, CEO, SURGE Therapeutics
Anthony Johnson, CEO, Kodikaz
Wyatt J. McDonnell, PhD, CEO, Infinimmune
Mani Mohindru, PhD, CEO & Director, Novasenta

10:30 am – Holmes II

Dialogue 4B
Seeding the Future:
Financing Tech and Bio for Mind-blowing Breakthroughs

Moderator:
George Santo, Executive Director – Middle Market Life Sciences Commercial Banking, JPMorgan

Panelists:
Milad Alucozai, DrPH, Head, Bio and Deep Tech, BoxOne Ventures
Laurence Blumberg, MD, Biotechnology Executive; Lecturer, Weill Cornell Medicine
Olga Danilchanka, PhD, Principal, MRL Ventures Fund, Merck
Kayj Shannon, Venture Partner, Alix Ventures

11:15 am
Adams/Kennedy I/Kennedy II

Presenting Companies

12:30 pm – Villard Ballroom

“Big Think” Lunch Plenary
Mavericks:
Navigating the Biotech Landscape in a Difficult Market

Moderator:
Tim Opler, PhD, Managing Director, Global Healthcare Group, Stifel

Panelists:
Sal Saraceno, Managing Director, Healthcare Investment, Capital One
Brad Sitko, Chief Investment Officer, XOMA
Robert Williamson, President & COO, Triumvira
Hanadie Yousef, PhD, CEO & Co-Founder, Juvena

2:00 pm
Adams/Kennedy I/Kennedy II

Presenting Companies

2:00 pm – 3:45 pm
Louis/Stanford/Rutherford

One-To-Ones

3:00 pm – Holmes I

Dialogue 5A
Alzheimer’s Disease:
A Brighter Horizon – Are We Turning the Corner on This Intractable Disease

Moderator:
Virginia Amann, Founder/Shareholder ENTENTE Network

Panelists:
Jonathan Behr, PhD, Partner, Dementia Discovery Fund (DDF)
Marc Jones, CEO, Altoida
Brent Vaughan, CEO, Cognito

3:00 pm – Holmes II

Dialogue 5B
Infectious Disease:
From Neglect to Respect Made Possible by New Technologies

Moderator:
Steve Brozak, DMH, Managing Partner & President, WBB Securities

Panelists:
Rick Bright, PhD, Pandemic Prevention & Response
Steven Damon, CEO, Micron Biomedical
Elizabeth Kavaler, MD, Founding Partner, Total Urology Care of New York
Karim Lalji, CEO, Microbion

3:45 pm – Villard Ballroom

Closing “Big Think" Plenary
Heard Around the Street:
What’s Buzzing in Biotech

Moderator:
Kimberly Ha, CEO & Founder, KKH Advisors

Panelists:
Max Bayer, Reporter, Fierce Biotech
Hilary Brueck, Correspondent, Insider
Julianna LeMieux, PhD, Deputy Editor in Chief, GEN
Sony Salzman, Coordinating Producer, Medical Unit, ABC News

5:00 pm – Villard Foyer

Closing Reception

Location

Event

Hello Partnering Virtual Platform

Virtual One-To-Ones

Recorded Conference Content